Open AccessComparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects
Author(s) -
Ling Yang,
Qi Shen,
Chao Hu,
Ying Wang,
Xiaohong Zhu,
Shiqing Shu,
Zhu Luo
Publication year - 2022
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s387508
Subject(s) - pharmacokinetics , cmax , tolerability , medicine , metabolite , pharmacology , oral administration , cyclooxygenase , elderly people , area under the curve , population , adverse effect , chemistry , gerontology , biochemistry , environmental health , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom